CompletedNot Applicable

Stress Ulcer Prophylaxis Practices in the Intensive Care Unit

Turkey (Türkiye)495 participantsStarted 2024-01-01

Plain-language summary

The present study aimed to examine the adherence of proton pump inhibitors (PPIs), commonly recommended for stress ulcer prevention (SUP) in patients in the intensive care unit (ICU), according to an international guideline. The objective of the study was to enhance the adherence of SUP prescriptions to the guideline, therefore preventing potential adverse effects and avoidable financial burden, and, consequently, attaining cost reduction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged ≥18 years, * ICU stay longer than 24 hours, * PPI use for SUP Exclusion Criteria: * Patients with a diagnosis of gastric cancer * Patients with a history of gastrointestinal issues * Individuals who have undergone subtotal or total gastrectomy * Those using proton pump inhibitors (PPIs) for treatment indications such as dual antiplatelet therapy * Patients admitted to the intensive care unit (ICU) with gastrointestinal bleeding

What they're measuring

Stress ulcer prophylaxis appropriate rate

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06620263

SponsorYunus Emre AYHAN

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-03

View on ClinicalTrials.gov More Stress Ulcer Prophylaxis trials